Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening

By Nienberg Christian   Garmann Claudia   Gratz Andreas   Bollacke Andre   Götz Claudia   Jose Joachim  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 6-6

MDPI

Access to resources Recommend Favorite

A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors

By Schnitzler Alexander   Gratz Andreas   Bollacke Andre   Weyrich Michael   Kuckländer Uwe   Wünsch Bernhard   Götz Claudia   Niefind Karsten   Jose Joachim  

Pharmaceuticals, Vol. 11, Iss. 1, 2018-02 ,pp. : 23-23

MDPI

Access to resources Recommend Favorite

D11-Mediated Inhibition of Protein Kinase CK2 Impairs HIF-1α-Mediated Signaling in Human Glioblastoma Cells

By Schaefer Susanne   Svenstrup Tina H.   Fischer Mette   Guerra Barbara  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor †

By Niefind Karsten   Bischoff Nils   Golub Andriy G.   Bdzhola Volodymyr G.   Balanda Anatoliy O.   Prykhod’ko Andriy O.   Yarmoluk Sergiy M.  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

The Link between Protein Kinase CK2 and Atypical Kinase Rio1

By Kubiński Konrad   Masłyk Maciej  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 21-21

MDPI

Access to resources Recommend Favorite